CGRP microinjection into the ventromedial or dorsomedial hypothalamic nucleus activates heat production

Abstract

Unilateral microinjection of calcitonin gene-related peptide (CGRP, 1.6 pmol; 0.2 μl) into the ventromedial hypothalamus (VMH) and dorsomedial hypothalamus (DMH) immediately increased oxygen consumption (VO 2), heart rate (HR), colonic temperature ( T co), and temperature of interscapular brown adipose tissue ( T IBAT) in urethane-anesthetized rats, whereas vehicle saline injection into the VMH and CGRP injection into other hypothalamic regions such as the preoptic area, lateral hypothalamic area, paraventricular nucleus, and bed nucleus of the stria terminalis had no effect. The effects of CGRP injection into the VMH were dose-dependent over the range of 0.016–1.6 pmol. CGRP administration to the lateral ventricle (LV) required 16–320 pmol to elicit similar degrees of responses that were observed after the injection into the VMH. The increase in T IBAT was always higher than that in T co after CGRP injection. Injection of [Cys(ACM) 2,7]hCGRPα, a selective CGRP 2 receptor agonist, did not induce any thermogenic effects. Human CGRP 8–37, a proposed CGRP 1 receptor antagonist, by itself induced heat production responses with no signs of inhibition of CGRP-induced responses. Thus, the receptor subtype of the thermogenic effect of CGRP could not be determined by the available pharmacological tools. The present results show that centrally administrated CGRP induces heat production in the BAT specifically through the VMH or DMH.